---
title: "12 Health Care Stocks Moving In Wednesday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291465819.md"
description: "In Wednesday's after-market session, several healthcare stocks moved significantly. Gainers included Curis (+9.0%), Humacyte (+5.45%), Medicus Pharma (+5.19%), Chemomab Therapeutics (+4.06%), OSR Health (+4.03%), and Solid Biosciences (+3.92%). Conversely, losers featured Galmed Pharmaceuticals (-14.4%), rYojbaba (-10.55%), Profusa (-7.77%), Aethlon Medical (-7.33%), Universe Pharmaceuticals (-7.2%), and NewGenIvf Group (-7.13%)."
datetime: "2026-07-01T21:05:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291465819.md)
  - [en](https://longbridge.com/en/news/291465819.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291465819.md)
---

# 12 Health Care Stocks Moving In Wednesday's After-Market Session

### Gainers

-   **Curis** (NASDAQ:CRIS) stock rose 9.0% to $0.46 during Wednesday's after-market session. The company's market cap stands at $20.3 million.
-   **Humacyte** (NASDAQ:HUMA) shares moved upwards by 5.45% to $0.71. The market value of their outstanding shares is at $210.4 million.
-   **Medicus Pharma** (NASDAQ:MDCX) shares increased by 5.19% to $0.42. The company's market cap stands at $25.2 million.
-   **Chemomab Therapeutics** (NASDAQ:CMMB) shares increased by 4.06% to $1.79. The company's market cap stands at $11.6 million.
-   **OSR Health** (NASDAQ:OSRH) shares moved upwards by 4.03% to $0.32. The market value of their outstanding shares is at $11.1 million.
-   **Solid Biosciences** (NASDAQ:SLDB) shares moved upwards by 3.92% to $10.6. The market value of their outstanding shares is at $983.5 million.

### Losers

-   **Galmed Pharmaceuticals** (NASDAQ:GLMD) stock fell 14.4% to $0.55 during Wednesday's after-market session. The market value of their outstanding shares is at $4.2 million.
-   **rYojbaba** (NASDAQ:RYOJ) stock declined by 10.55% to $2.8. The market value of their outstanding shares is at $28.9 million.
-   **Profusa** (NASDAQ:PFSA) stock declined by 7.77% to $0.12.
-   **Aethlon Medical** (NASDAQ:AEMD) stock fell 7.33% to $0.7. The company's market cap stands at $1.9 million.
-   **Universe Pharmaceuticals** (NASDAQ:UPC) stock fell 7.2% to $5.16. The market value of their outstanding shares is at $3.9 million.
-   **NewGenIvf Group** (NASDAQ:NIVF) stock decreased by 7.13% to $0.51. The company's market cap stands at $5.3 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [CMMB.US](https://longbridge.com/en/quote/CMMB.US.md)
- [CRIS.US](https://longbridge.com/en/quote/CRIS.US.md)
- [PFSA.US](https://longbridge.com/en/quote/PFSA.US.md)
- [OSRH.US](https://longbridge.com/en/quote/OSRH.US.md)
- [SLDB.US](https://longbridge.com/en/quote/SLDB.US.md)
- [GLMD.US](https://longbridge.com/en/quote/GLMD.US.md)
- [AEMD.US](https://longbridge.com/en/quote/AEMD.US.md)
- [UPC.US](https://longbridge.com/en/quote/UPC.US.md)
- [NIVF.US](https://longbridge.com/en/quote/NIVF.US.md)
- [HUMA.US](https://longbridge.com/en/quote/HUMA.US.md)
- [MDCX.US](https://longbridge.com/en/quote/MDCX.US.md)
- [RYOJ.US](https://longbridge.com/en/quote/RYOJ.US.md)
- [HUMAW.US](https://longbridge.com/en/quote/HUMAW.US.md)
- [MDCXW.US](https://longbridge.com/en/quote/MDCXW.US.md)
- [OSRHW.US](https://longbridge.com/en/quote/OSRHW.US.md)
- [NVACW.US](https://longbridge.com/en/quote/NVACW.US.md)
- [NIVFW.US](https://longbridge.com/en/quote/NIVFW.US.md)

## Related News & Research

- [BTIG Research Reaffirms Buy Rating for Humacyte (NASDAQ:HUMA)](https://longbridge.com/en/news/294096797.md)
- [Solid Biosciences Inc. (NASDAQ:SLDB) Given Average Rating of "Moderate Buy" by Analysts](https://longbridge.com/en/news/293836871.md)
- [Curis doses first five patients in TakeAim CLL combo trial of emavusertib, zanubrutinib](https://longbridge.com/en/news/294362171.md)
- [09:03 ETAssureCare® and CURIS Partner to Ensure RHT Funding Builds Infrastructure That Outlasts the Program](https://longbridge.com/en/news/293937050.md)
- [NewGenIvf Boosts K25.ai Ownership To 13% Via $250 Mln Deal, Shares Down In Pre-Market](https://longbridge.com/en/news/293939041.md)